Pd-catalyzed enantioselective aerobic oxidation of secondary alcohols: Applications to the total synthesis of alkaloids

Journal of the American Chemical Society

Volumn 130, Issue 41, 2008, Pages 13745-13754

  Krishnan, Shyam ^a   Bagdanoff, Jeffrey T ^a   Ebner, David C ^a   Ramtohul, Yeeman K ^a   Tambar, Uttam K ^a   Stoltz, Brian M ^a  

^a California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL OXYGEN DEMAND; COMPLEXATION; OXIDATION; PALLADIUM;

ABSOLUTE CONFIGURATION; AEROBIC OXIDATIONS; ASYMMETRIC OXIDATION; ENANTIO-SELECTIVE SYNTHESIS; ENANTIOSELECTIVE; INSERTION REACTIONS; POLYCYCLIC FRAMEWORKS; SECONDARY ALCOHOLS; STEREOCENTERS; TOTAL SYNTHESIS;

SYNTHESIS (CHEMICAL);

ALCOHOL DERIVATIVE; ALKALOID DERIVATIVE; AMURENSININE; AURANTIOCLAVINE; LOBELINE; PALLADIUM; SEDAMINE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CATALYST; CHEMICAL REACTION; ENANTIOSELECTIVITY; OXIDATION; REACTION ANALYSIS; SYNTHESIS;

AEROBIOSIS; ALCOHOLS; ALKALOIDS; BIOLOGICAL PRODUCTS; CATALYSIS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NITROGEN; OXIDATION-REDUCTION; PALLADIUM; STEREOISOMERISM;

EID: 53849126527     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja804738b     Document Type: Article

References (113)

1. For recent reviews on the enantioselective synthesis of amines, see: (a) Moody, C. J. Angew. Chem., Int. Ed. 2007, 46, 9148.
2. (b) Ouellet, S. G.; Walji, A. M.; MacMillan, D. W. C. Acc. Chem. Res. 2007, 40, 1327.
3. (c) Skucas, E.; Ngai, M.-Y.; Komanduri, V.; Krische, M. J. Acc. Chem. Res. 2007, 40, 1394.
4. (d) Masson, G.; Housseman, C.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 4614.
5. (e) Li, G.; Saibau, K.; Timmons, C. Eur. J. Org. Chem. 2007, 17, 2745.
6. (f) Bräse, S.; Baumann, T.; Dahmen, S.; Vogt, H. Chem. Commun. 2007, 1881.
7. (g) Maruoka, K.; Ooi, T.; Kano, T. Chem. Commun. 2007, 1487.
8. (h) Ellman, J. A. Pure Appl. Chem. 2003, 75, 39.
9. (i) Roesky, P. W.; Mueller, T. E. Angew. Chem., Int. Ed. 2003, 42, 2708.
10. (j) Enders, D.; Reinhold, U. Tetrahedron: Asymmetry 1997, 8, 1895.
11. For selected examples of synthesis of amines directly from alcohols, their corresponding esters, carbonates, sulfonate esters, or alkyl halides, see: (a) Kan, T.; Fukuyama, T. Chem. Commun. 2004, 353.
12. (b) Fujita, K-i.; Fujii, T.; Yamaguchi, R Org. Lett. 2004, 6, 3525.
13. (c) Evans, P. A.; Robinson, J. E.; Nelson, J. D. J. Am. Chem. Soc. 1999, 121, 6761.
14. (d) Scriven, E. F. V.; Turnbull, K. Chem. Rev. 1988, 88, 297.
15. (e) Kolasa, T.; Miller, M. J. J. Org. Chem. 1987, 52, 4978.
16. (f) Bestmann, H. J.; Wölfel, G. Chem. Ber. 1984, 117, 1250.
17. (g) Trost, B. M.; Keinan, E. J. Org. Chem. 1979, 44, 3451.
18. (h) Nordlander, J. E.; Catalane, D. B.; Eberlein, T. H.; Farkas, L. V.; Howe, R. S.; Stevens, R. M.; Tripoulas, N. A.; Stansfield, R. E.; Cox, J. L. Tetrahedron Lett. 1978, 50, 4987.
19. (i) Jonczyk, A.; Ochal, Z.; Makosza, M. Synthesis 1978, 882.
20. (j) Zwierzak, A.; Podstawczynska, I. Angew. Chem., Int. Ed. Engl. 1977, 16, 702.
21. (k) Hendrickson, J. B.; Joffee, I. J. Am. Chem. Soc. 1973, 95, 4083.
22. (l) Mitsunobu, O.; Wada, M.; Sano, T. J. Am. Chem. Soc. 1972, 94, 679.
23. (m) Gibson, M. S.; Bradshaw, R. W. Angew. Chem., Int. Ed. Engl. 1968, 7, 919.
24. For recent reviews of asymmetric desymmetrization, see: (a) Rendler, S.; Ostreich, M. Angew. Chem., Int. Ed. 2008, 47, 248.
25. (b) Rovis, T. Recent Advances in Catalytic Asymmetric Desymmetrization Reactions. In New Frontiers in Asymmetric Catalysis; Mikami, K., Lautens, M., Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, 2007; pp 275-311.
26. (c) Atodiresei, I.; Schiffers, I.; Bolm, C. Chem. Rev. 2007, 107, 5683.
27. (d) Schneider, C. Synthesis 2006, 23, 3919.
28. (e) Garcia-Urdiales, E.; Alfonso, I.; Gotor, V. Chem. Rev. 2005, 105, 313.
29. (a) Ferreira, E. M.; Stoltz, B. M. J. Am. Chem. Soc. 2001, 123, 7725.
30. (b) Jensen, D. R.; Pugsley, J. S.; Sigman, M. S. J. Am. Chem. Soc. 2001, 123, 7475.
31. 2, see: Trend, R. M.; Stoltz, B. M J. Am. Chem. Soc. 2004, 126, 4482.
32. Kozlovskii, A. G.; Solov'eva, T. F.; Sahkarovskii, V. G.; Adanin, V. M. Dokl. Akad. Nauk SSSR 1981, 260, 230.
33. (a) Numata, A.; Takahashi, C.; Ito, Y.; Takada, T.; Kawai, K.; Usami, Y.; Matsumura, E.; Imachi, M.; Ito, T.; Hasegawa, T. Tetrahedron Lett. 1993, 34, 2355.
34. (b) Jadulco, R.; Edrada, R. A.; Ebel, R.; Berg, A.; Schaumann, K.; Wray, V.; Steube, K.; Proksch, P. J. Nat. Prod. 2004, 67, 78.
35. (c) Hayashi, H.; Matsumoto, H.; Akiyama, K. Biosci. Biotechnol. Biochem. 2004, 68, 753.
36. (d) Dalsgaard, P. W.; Blunt, J. W.; Munro, M. H. G.; Frisvad, J. C.; Christophersen, C. J. Nat. Prod. 2005, 68, 258.
37. For total syntheses of aurantioclavine, see: (a) Somei, M.; Yamada, F. Heterocycles 2007, 74, 943.
38. (b) Yamada, F.; Makita, Y.; Suzuki, T.; Somei, M. Chem. Pharm. Bull. 1985, 33, 2162.
39. (c) Hegedus, L. S.; Toro, J. L.; Miles, W. H.; Harrington, P. J. J. Org. Chem. 1987, 52, 3319.
40. (a) May, J. A.; Stoltz, B. M. Tetrahedron 2006, 62, 5262.
41. (b) May, J. A.; Zeidan, R. K.; Stoltz, B. M. Tetrahedron Lett. 2003, 44, 1203.
42. (a) Boit, H. G.; Flentje, H. Naturwissenschaften 1960, 47, 180.
43. (b) Gözler, B.; Lantz, M. S.; Shamma, M. J. Nat. Prod. 1983, 46, 293.
44. For discussions of the biological activity of the isopavine alkaloids, see: (a) Weber, E.; Keana, J.; Barmettler, P. PCT Int. Appl. 106019w, 1991; Chem. Abstr. 1991, 115, 106019w.
45. (b) Childers, W. E.; Abou-Gharbia, M. A. U.S. Patent 4,940,789, 1990; Chem. Abstr. 1990, 113, 191190w.
46. For selected syntheses of isopavine alkaloids, see: (a) Gözler, B. Pavine and Isopavine Alkaloids. In The Alkaloids; Brossi, A., Ed.; Academic Press: New York, 1987; Vol. 31, pp 343-356.
47. (b) Meyers, A. I.; Dickman, D. A.; Boes, M. Tetrahedron 1987, 43, 5095.
48. (c) Gottlieb, L.; Meyers, A. I. J. Org. Chem. 1990, 55, 5659.
49. (d) For a synthesis of (-)-amurensinine, see: Cardio, L.; Badía, D.; Domínguez, E.; Vicario, J. L.; Tellitu, I. J. J. Org. Chem. 1997, 62, 6716.
50. (e) Shinohara, T.; Takeda, A.; Toda, J.; Sano, T. Heterocycles 1998, 48, 981.
51. (f) Hanessian, S.; Mauduit, M. Angew. Chem., Int. Ed. 2001, 40, 3810.
52. (g) Dragoli, D. R.; Burdett, M. T.; Ellman, J. A. J. Am. Chem. Soc. 2001, 123, 10127.
53. For our preliminary communication of the enantioselective synthesis of (+)-amurensinine, see: Tambar, U. K.; Ebner, D. C.; Stoltz, B. M. J. Am. Chem. Soc. 2006, 128, 11752.
54. For a review of chemistry and biology of the Lobelia alkaloids, see: Felpin, F.-X.; Lebreton, J. Tetrahedron 2004, 60, 10127.
55. For syntheses of racemic (±)-lobeline, see: (a) Wieland, H.; Drishaus, I. Annalen 1929, 473, 102.
56. (b) Wieland, H.; Koschara, W.; Dane, E. Annalen 1929, 473, 118.
57. (c) Scheuing, G.; Winterhalder, L. Justus Liebigs Ann. Chem. 1929, 473, 126.
58. (d) Wieland, H.; Koshara, W.; Dane, E.; Renz, J.; Schwarze, W.; Linde, W. Justus Liebigs Ann. Chem. 1939, 540, 103.
59. (e) Parker, W.; Raphael, R. A.; Wilkinson, D. I. J. Chem. Soc. 1959, 2433.
60. (f) For an X-ray crystallography study of (-)-lobeline salts, see: Glaser, R.; Hug, P.; Drouin, M.; Michael, A. J. Chem. Soc., Perkin Trans. 2 1992, 1071.
61. (g) For a study of the biosynthesis of (-)-lobeline, see: Keogh, M. F.; O'Donovan, D. G. J. Chem. Soc. 1970, 2470.
62. (a) Millspaugh, C. F. Lobelia inflata. American medicinal plants: an illustrative and descriptive guide to plants indigenous to and naturalized in the United States which are used in medicine; Dover: New York, 1974; pp 385-388.
63. (b) Dwoskin, L. A.; Crooks, P. A. Biochem. Pharmacol. 2002, 63, 89.
64. (c) Thayer, A. M. Chem. Eng. News 2006, 84 (39), 21.
65. Zheng, G.; Dwoskin, L. P.; Deacuic, A. G.; Norrholm, S. D.; Crooks, P. A. J. Med. Chem. 2005, 48, 5551.
66. The epimerization at C(3) is believed to be a base-catalyzed equilibration via transient retro-conjugate addition intermediate 19. See also refs 19a, 19b, and 19d. (Chemical Equation Presented)
67. For enantioselective syntheses of (-)-lobeline, see: (a) Compere, D.; Marazano, C.; Das, B. C. J. Org. Chem. 1999, 64, 4528.
68. (b) Felpin, F.-X.; Lebreton, J. J. Org. Chem. 2002, 67, 9192.
69. (c) Klingler, F.-D.; Sobotta, R. (Boehringer Ingelheim). U.S. Patent 2006014791, 2006.
70. (d) Birman, V. B.; Jiang, H.; Li, X. Org. Lett. 2007, 9, 3237.
71. (a) Marion, L.; Lavigne, R.; Lemay, L Can. J. Chem. 1951, 29, 347.
72. (b) Franck, B. Chem. Ber. 1958, 91, 2803.
73. (c) Logar, C.; Mesicek, M.; Perpar, M.; Seles, E. Farm. Vestn. 1974, 21; Chem. Abstr. 1975, 82, 81926h.
74. (d) Krasnov, E. A.; Petrova, L. V.; Bekker, E. F. Khim. Prir. Soedin. 1977, 585; Chem. Abstr. 1977, 87, 164249k.
75. For a review of syntheses of the Sedum alkaloids, see: (a) Bates, R. W.; Sa-Ei, K. Tetrahedron 2002, 58, 5957.
76. For recent syntheses of either enantiomer of sedamine, see: (b) Bates, R. W.; Nemeth, J. A.; Snell, R. H. Synthesis 2008, 1033.
77. (c) Fustero, S.; Jiménez, D.; Moscardó, J.; Catalán, S.; del Pozo, C. Org. Lett. 2007, 9, 5283.
78. (d) Yadav, J. S.; Reddy, M. S.; Rao, P. P.; Prasad, A. R. Synthesis 2006, 4005.
79. (e) Yadav, J. S.; Reddy, M. S.; Rao, P. P.; Prasad, A. R. Tetrahedron Lett. 2006, 47, 4397.
80. (f) Bates, R. W.; Boonsoombat, J. Org. Biomol. Chem. 2005, 3, 520.
81. (g) Josephson, N. S.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 3734.
82. (h) Zheng, G.; Dwoskin, L. P.; Crooks, P. A. J. Org. Chem. 2004, 69, 8514.
83. (i) Angoli, M.; Barilli, A.; Lesma, G.; Passarella, D.; Riva, S.; Silvani, A.; Danieli, B. J. Org. Chem. 2003, 68, 9525.
84. (j) Cossy, J.; Willis, C.; Bellosta, V.; BouzBouz, S. J. Org. Chem. 2002, 67, 1982.
85. (a) Tambar, U. K.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127, 5340.
86. Others have disclosed similar aryne insertions since our initial report, see: (b) Yoshida, H.; Watanabe, M.; Ohshita, J.; Kunai, A. Chem. Commun. 2005, 3292.
87. (c) Yoshida, H.; Watanabe, M.; Ohshita, J.; Kunai, A. Tetrahedron Lett. 2005, 46, 6729.
88. Kozikowski, A. P.; Ishida, H.; Chen, Y.-Y. J. Org. Chem. 1980, 45, 3350.
89. Bachki, A.; Foubelo, F.; Yus, M. Tetrahedron: Asymmetry 1996, 7, 2997.
90. slow). The selectivity factor can be expressed in terms of enantiomeric excess (ee) of the remaining alcohol and the conversion (c) of the alcohol to the corresponding ketone, i.e., s = ln[(1- c)(1-ee)]/ln[(1- c)(1 +ee)]. For s > 10, synthetically useful quantities of enantioenriched alcohol can be accessed. For example, an oxidative kinetic resolution with s = 10 at 62% conversion would afford recovery of alcohol of 90% ee. See also: Kagan, H. B., Fiaud, J. C. In Topics in Stereochemistry; Eliel, E. L., Ed.; Wiley & Sons: New York, 1988; Vol. 18, pp 249-330.
91. Mitsunobu, O. Synthesis 1981, 1.
92. Fukuyama, T.; Jow, C.-K.; Cheung, M. Tetrahedron Lett. 1995, 36, 6373.
93. For reviews of the Stille cross-coupling reaction, see: (a) Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508.
94. (b) Farina, V.; Krishnamurthy, V.; Scott, W. J. Org. React. 1997, 50, 1.
95. (c) Littke, A. F.; Fu, G. C. Angew. Chem., Int. Ed. 2002, 41, 4176.
96. (d) Espinet, P.; Echavarren, A. M. Angew. Chem., Int. Ed. 2004, 43, 4704.
97. (a) Knights, E. F.; Brown, H. C. J. Am. Chem. Soc. 1968, 90, 5281.
98. (b) Brown, H. C.; Knights, E. F.; Scouten, C. G. J. Am. Chem. Soc. 1974, 96, 7765.
99. See Supporting Information for details.
100. Morris, L. J. J. Lipid Res. 1966, 7, 717.
101. Yasuhara, A.; Sakamoto, T. Tetrahedron Lett. 1998, 39, 595.
102. (a) Wenkert, E.; Davis, L. L.; Mylari, B. L.; Solomon, M. F.; Da Silva, R. R.; Shulman, S.; Warnet, R. J.; Ceccherelli, D.; Curini, M.; Pellicciari, R. J. J. Org. Chem. 1982, 47, 3242.
103. (b) Taber, D. F.; Petty, E. H. J. Org. Chem. 1982, 47, 4808.
104. Himeshima, Y.; Sonoda, T.; Kobayashi, H. Chem. Lett. 1983, 1211.
105. Thompson, A. S.; Humphrey, G. R.; DeMarco, A. M.; Mathre, D. J.; Grabowski, E. J. J. J. Org. Chem. 1982, 47, 4808.
106. Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
107. Nishimura, T.; Onoue, T.; Ohe, K.; Uemura, S. J. Org. Chem. 1999, 64, 6750.
108. We have recently accomplished a formal synthesis of the naturally occurring enantiomer of amurensinine using a readily accessible diamine ligand that serves as a mimic for (+)-sparteine in the oxidative kinetic resolution. See: Ebner, D. C.; Trend, R. M.; Genet, C.; McGrath, M. J.; O'Brien, P.; Stoltz, B. M Angew. Chem., Int. Ed. 2008, 47, 6367-6370.
109. Molander, G. A.; Romero, J. A. C. Tetrahedron 2005, 61, 2631.
110. A rationale for the observed selectivity follows from the calculated conformational equilibria of cis,cis-1,4-cyclooctadiene. See: Anet, F. A. L.; Yavari, I. J. Am. Chem. Soc. 1977, 99, 6986. Also see Supporting Information for a stereochemical model.
111. Bagdanoff, J. T.; Stoltz, B. M. Angew. Chem., Int. Ed. 2004, 43, 353.
112. The enantiomeric excess was determined after derivatization of lobeline by the method described in ref 21h. See Supporting Information for details.
113. 3OD (2 h).